KR920019344A - Prevention and treatment composition of liver disease using α-linolenic acid - Google Patents

Prevention and treatment composition of liver disease using α-linolenic acid Download PDF

Info

Publication number
KR920019344A
KR920019344A KR1019910005730A KR910005730A KR920019344A KR 920019344 A KR920019344 A KR 920019344A KR 1019910005730 A KR1019910005730 A KR 1019910005730A KR 910005730 A KR910005730 A KR 910005730A KR 920019344 A KR920019344 A KR 920019344A
Authority
KR
South Korea
Prior art keywords
liver disease
composition
linolenic acid
prevention
treatment composition
Prior art date
Application number
KR1019910005730A
Other languages
Korean (ko)
Other versions
KR940000004B1 (en
Inventor
여영근
Original Assignee
이순목
주식회사 우방랜드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이순목, 주식회사 우방랜드 filed Critical 이순목
Priority to KR1019910005730A priority Critical patent/KR940000004B1/en
Publication of KR920019344A publication Critical patent/KR920019344A/en
Application granted granted Critical
Publication of KR940000004B1 publication Critical patent/KR940000004B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

내용 없음No content

Description

α-리놀렌산을 이용한 간장질환의 예방 및 치료 조성물Prevention and treatment composition of liver disease using α-linolenic acid

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (6)

유효성분으로서 다음 화학 구조식(I)을 가진 α-리놀렌산 또는 그를 함유한 천연물이나 그 추출액을 함유하는 간장질환 예방 및 치료제 조성물.Liver disease prevention and treatment composition containing (alpha) -linolenic acid which has the following chemical formula (I), a natural product containing the same, or its extract as an active ingredient. 제1항에 있어서, 천연물이 들깨 또는 아마씨인 간장질환 예방 및 치료제 조성물.The composition for preventing and treating liver disease according to claim 1, wherein the natural product is perilla or flaxseed. 제1항에 있어서, 간장질환이 간지질에 기인된 것인 조성물.The composition of claim 1, wherein the liver disease is due to hepatic lipids. 제1항에 있어서, 비타민 E를 추가로 포함하는 조성물.The composition of claim 1, further comprising vitamin E. 제1항 내지 4항 중 어느 한 항에 있어서, 그 제형이 현탁액제 또는 캅셀제 형태로 제조되는 조성물.The composition according to any one of claims 1 to 4, wherein the formulation is prepared in the form of a suspension or a capsule. 제5항에 있어서, 캅셀제가 연질 캅셀제인 조성물.The composition according to claim 5, wherein the capsule is a soft capsule. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910005730A 1991-04-10 1991-04-10 Pharmaceutical preparation containing alpha-linolenic acid used for liver disease KR940000004B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910005730A KR940000004B1 (en) 1991-04-10 1991-04-10 Pharmaceutical preparation containing alpha-linolenic acid used for liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910005730A KR940000004B1 (en) 1991-04-10 1991-04-10 Pharmaceutical preparation containing alpha-linolenic acid used for liver disease

Publications (2)

Publication Number Publication Date
KR920019344A true KR920019344A (en) 1992-11-19
KR940000004B1 KR940000004B1 (en) 1994-01-05

Family

ID=19313095

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910005730A KR940000004B1 (en) 1991-04-10 1991-04-10 Pharmaceutical preparation containing alpha-linolenic acid used for liver disease

Country Status (1)

Country Link
KR (1) KR940000004B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230085543A (en) 2021-12-07 2023-06-14 안창균 Composition for the prevention of hangover and improving liver functionand Manufacturing method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230085543A (en) 2021-12-07 2023-06-14 안창균 Composition for the prevention of hangover and improving liver functionand Manufacturing method thereof

Also Published As

Publication number Publication date
KR940000004B1 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
ATE129894T1 (en) SHORT-BED, MONOUNSATURATED FATTY ACIDS CONTAINING FOODS AND PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS.
KR950007859A (en) Rapamycin formulations for oral administration
DK312583A (en) CORTICOID CONTAINING TOPIC APPLICATION
KR880009639A (en) Sustained Release Matrix Formulations
KR890000085A (en) Essential Fatty Acid Compositions
KR940005282A (en) Oral Pharmaceutical Compositions Containing Anthocyanosides
ES2051827T3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING RICINO POLYETOXILADO OIL.
KR950007857A (en) Rapamycin preparations for oral administration
KR920019345A (en) Acne therapeutic composition containing icosapentanoic acid and α-linolenic acid
KR890001525A (en) Sustained-release transdermal formulation
KR910002426A (en) A functional external preparation
KR930001903A (en) Ubide carrenone oral aqueous solution preparation
DK0808154T3 (en) Formulations of compounds such as nanoparticle dispersions in digestible oils or fatty acids
NO891220L (en) COMPOSITION CONTAINING SALICYLIC ACID FOR TREATING LEPIDOSE.
JPS5653608A (en) Emulsified stick cosmetic
KR920019344A (en) Prevention and treatment composition of liver disease using α-linolenic acid
ATE110274T1 (en) AGENTS FOR IMPROVING SPECIFIC PROPERTIES OF BLOOD.
KR920019343A (en) Composition for preventing and treating vascular disease using α-linolenic acid
KR890011594A (en) Pharmaceutical composition of 4-aroylimidazol-2-one
KR900013959A (en) γ-carbline or their pharmaceutically acceptable acid addition salts and / or hydrates, and pharmaceutical compositions composed thereof
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR940003570A (en) Improved fragrance composition
KR880009644A (en) Weak composition for treating ulcerative bowel disease
KR920000319A (en) Cancer prevention method
PT1100463E (en) NEW INJECTABLE FORMULATIONS CONTAINING RAMOPLANIN

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20021213

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee